Prognostic Value of Lenalidomide Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM); A Single Center Experience-A Retrospective Study
INTRODUCTION: Multiple myeloma (MM) is the most common malignant plasma cell disease (1). Advances in treatment in the last 10 years have enabled longer overall survival and progression-free survival. Despite these advances in treatment, patients who are followed up without treatment recur after aut...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Van Yuzuncu Yil University, School of Medicine
2021-04-01
|
Series: | Van Tıp Dergisi |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-87369 |